Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Blood. 2020 Aug 20;136(8):936-945. doi: 10.1182/blood.2020005288.
Blood. 2020.
PMID: 32325490
Free PMC article.
Clinical Trial.
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.
Yimer H, Melear J, Faber E, Bensinger WI, Burke JM, Narang M, Stevens D, Gunawardena S, Lutska Y, Qi K, Ukropec J, Qi M, Lin TS, Rifkin RM.
Yimer H, et al. Among authors: lutska y.
Br J Haematol. 2019 May;185(3):492-502. doi: 10.1111/bjh.15806. Epub 2019 Mar 3.
Br J Haematol. 2019.
PMID: 30828799
Free PMC article.
Clinical Trial.
Item in Clipboard
Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN.
Voorhees PM, Rodriguez C, Reeves B, Nathwani N, Costa LJ, Lutska Y, Bobba P, Hoehn D, Pei H, Ukropec J, Qi M, Lin TS, Richardson PG.
Voorhees PM, et al. Among authors: lutska y.
Blood Adv. 2021 Feb 23;5(4):1092-1096. doi: 10.1182/bloodadvances.2020003642.
Blood Adv. 2021.
PMID: 33606004
Free PMC article.
Item in Clipboard
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study.
Yimer H, Melear J, Faber E, Bensinger WI, Burke JM, Narang M, Stevens D, Gray KS, Lutska Y, Bobba P, Qi K, Hoehn D, Qi M, Lin TS, Rifkin RM.
Yimer H, et al. Among authors: lutska y.
Leuk Lymphoma. 2022 Oct;63(10):2383-2392. doi: 10.1080/10428194.2022.2076847. Epub 2022 Jun 22.
Leuk Lymphoma. 2022.
PMID: 35730586
Item in Clipboard
Cite
Cite